Company intelligence / Profile preview

True Positive Medical Devices

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

The company developed and commercialized an imaging software analytics platform providing information-rich brain biomarkers to support diagnosis, prognosis and monitoring in neurology, now integrated into Qynapse's QyScore and broader AI platform for brain diseases[1][3][4][7][9].

Therapeutic areas: PsychiatryCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Qynapse (strategic technology alliance and acquisition integrating TPMD into Qynapse Canada and Qynapse's AI imaging platform for brain diseases)[4].McGill University (spin-off origin and ongoing scientific collaboration in brain imaging and AI)[4].Université Laval (spin-off origin and ongoing scientific collaboration in brain imaging and AI)[4].

Beyond the preview

Go deeper on True Positive Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on True Positive Medical Devices.

Explore the full profile